GSK2190915 Pediatric Study
NCT01286844
·
clinicaltrials.gov ↗
PHASE2
Phase
WITHDRAWN
Status
INDUSTRY
Sponsor class
Conditions
Asthma
Interventions
DRUG:
GSK2190915A 5mg
DRUG:
GSK2190915A 10mg
DRUG:
GSK2190915A 25mg
DRUG:
GSK2190915A 50mg
DRUG:
GSK2190915A 100mg
Sponsor
GlaxoSmithKline